These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 10913248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct.
    Chow CS, Barnes CM, Lippard SJ.
    Biochemistry; 1995 Mar 07; 34(9):2956-64. PubMed ID: 7893709
    [Abstract] [Full Text] [Related]

  • 3. Structural and kinetic studies of a cisplatin-modified DNA icosamer binding to HMG1 domain B.
    Jamieson ER, Jacobson MP, Barnes CM, Chow CS, Lippard SJ.
    J Biol Chem; 1999 Apr 30; 274(18):12346-54. PubMed ID: 10212205
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.
    Cohen SM, Mikata Y, He Q, Lippard SJ.
    Biochemistry; 2000 Sep 26; 39(38):11771-6. PubMed ID: 10995245
    [Abstract] [Full Text] [Related]

  • 6. HMG domain proteins induce sharp bends in cisplatin-modified DNA.
    Chow CS, Whitehead JP, Lippard SJ.
    Biochemistry; 1994 Dec 20; 33(50):15124-30. PubMed ID: 7999772
    [Abstract] [Full Text] [Related]

  • 7. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM, Rould MA, He Q, Pabo CO, Lippard SJ.
    Nature; 1999 Jun 17; 399(6737):708-12. PubMed ID: 10385126
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE, Zamble DB, Lippard SJ, Essigmann JM.
    Biochemistry; 1998 Jan 06; 37(1):352-62. PubMed ID: 9425057
    [Abstract] [Full Text] [Related]

  • 11. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM, Whitehead JP, Raju NL, Lippard SJ.
    Biochemistry; 1997 Dec 02; 36(48):14807-15. PubMed ID: 9398202
    [Abstract] [Full Text] [Related]

  • 12. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
    Kane SA, Lippard SJ.
    Biochemistry; 1996 Feb 20; 35(7):2180-8. PubMed ID: 8652559
    [Abstract] [Full Text] [Related]

  • 13. Two mutations of basic residues within the N-terminus of HMG-1 B domain with different effects on DNA supercoiling and binding to bent DNA.
    Stros M.
    Biochemistry; 2001 Apr 17; 40(15):4769-79. PubMed ID: 11294645
    [Abstract] [Full Text] [Related]

  • 14. Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box B-domain of HMG1 protein to supercoiled DNA.
    Stros M, Reich J.
    Eur J Biochem; 1998 Jan 15; 251(1-2):427-34. PubMed ID: 9492314
    [Abstract] [Full Text] [Related]

  • 15. Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo.
    McA'Nulty MM, Whitehead JP, Lippard SJ.
    Biochemistry; 1996 May 14; 35(19):6089-99. PubMed ID: 8634251
    [Abstract] [Full Text] [Related]

  • 16. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.
    Mikata Y, He Q, Lippard SJ.
    Biochemistry; 2001 Jun 26; 40(25):7533-41. PubMed ID: 11412107
    [Abstract] [Full Text] [Related]

  • 17. Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.
    Farid RS, Bianchi ME, Falciola L, Engelsberg BN, Billings PC.
    Toxicol Appl Pharmacol; 1996 Dec 26; 141(2):532-9. PubMed ID: 8975778
    [Abstract] [Full Text] [Related]

  • 18. HMG1 protein inhibits the translesion synthesis of the major DNA cisplatin adduct by cell extracts.
    Hoffmann JS, Locker D, Villani G, Leng M.
    J Mol Biol; 1997 Jul 25; 270(4):539-43. PubMed ID: 9245584
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
    Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ.
    Nature; 1995 Oct 19; 377(6550):649-52. PubMed ID: 7566180
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin.
    Bruhn SL, Pil PM, Essigmann JM, Housman DE, Lippard SJ.
    Proc Natl Acad Sci U S A; 1992 Mar 15; 89(6):2307-11. PubMed ID: 1372440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.